Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment completed for phase I/II study of 131I-TM-601 in glioma

July 14, 2003

Promising activity reported for Nipent combination therapy in NHL

July 14, 2003

New antiproliferative agents in Sankyo development pipeline

July 14, 2003

Cytotoxic macrolactones discovered at GBF assumed to act by inhibiting V-ATPase

July 14, 2003

New telomerase inhibitors under study at Kyowa Hakko

July 14, 2003

Reduced toxicity and improved antitumor effects for IL-2 when coadministered with M-40403

July 14, 2003

Potential new molecularly targeted therapies for diseases related to activated PDGFR-alpha

July 14, 2003

Beneficial effects described for bortezomib in patients with relapsed, refractory myeloma

July 14, 2003

Clinical efficacy of tetrathiomolybdate in advanced kidney cancer

July 11, 2003

FibroGen awarded grant to develop cancer therapies

July 11, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...